Subject: Cataphora | RSP Global Risk - UPDATE
From: "Neil Callahan" <[email-masked]>
To: "'Eric Schwerin'" <[email-masked]>, <[email-masked]>, "'Chris Heinz'" <[email-masked]>, "'Hunter Biden'" <[email-masked]>, "'Jay Rouse'" <[email-masked]>, "'Robert Mitchell'" <[email-masked]>
Date: Sat, 23 Oct 2010 12:18:42 -0400

Hey guys,

Rob had a very successful trip out West this week.

First off he had the CEO sign the SOW, so we are in business.

And he spent the better part of two days working with their management team
on the USG opportunity.  We both think there is a healthy up sell
opportunity here as we get going in the next few months.

Attached is his overview presentation which I think is helpful to Cataphora,
but is also good market intelligence for us to understand the Global Risk
marketplace.  I'd like to have Rob brief us in an upcoming session when we
are all together.

Let's make it a priority to close out on the RSP Global Risk discussion this
week so we can focus on the business at hand and not create any undue risk
to servicing Cataphora.

Have a great weekend.

Best,

Neil

----------------------------------------------------------------------------
--------------

Neil Callahan

Rosemont Seneca

401 Greenwich Street, Suite 400 | New York NY 10013 | 212-933-9965 |
212-796-4037

1010 Wisconsin Avenue, Suite 705 | Washington DC 20007 | 202-333-1880

917-945-9516 (mobile) 

866-749-8879  (fax)